Single-base 5hmC profiling for researchers who need confident, reproducible epigenomic signals—without guesswork.
From sample QC and optimized library construction to bioinformatics and interpretation, we help you pinpoint differential 5hmC regions and link them to genes and pathways (RUO).
Get a clear plan for inputs, depth, replicates, and expected outputs—so your project is designed right from day one.

ACE Sequencing (APOBEC-Coupled Epigenetic Sequencing, ACE-seq) is an enzymatic, genome-wide approach for mapping 5-hydroxymethylcytosine (5hmC) at single-base resolution. It supports differential 5hmC analysis across conditions or cohorts and helps interpret hydroxymethylation changes in regulatory elements and gene bodies.
5hmC is an epigenomic mark widely studied in developmental regulation, cellular differentiation, aging-related epigenomic remodeling, and disease-mechanism research. With CD Genomics, you receive an end-to-end workflow—from sample QC to bioinformatics and reporting—designed to deliver reproducible, interpretation-ready outputs.
ACE Sequencing is a revolutionary NGS-based method that specifically detects 5-hydroxymethylcytosine. It utilizes the engineered enzyme APOBEC3A (A3A) to deaminate unmodified C and 5mC to U, while 5hmC—protected by glucosylation—remains as C. This clever biochemical trick allows precise discrimination and quantification of 5hmC without the harsh chemicals used in bisulfite sequencing.
The schematic diagram of the technical principle is as follows:
1)β-Glucosyltransferase (βGT) selectively glucosylates 5hmC to form 5ghmC, which is protected from A3A deamination.
2)The A3A enzyme specifically deaminates unmodified C and 5mC to U, while 5hmC remains as C, enabling its specific detection.
Comparison of several genome-wide methylation methods:
| Method | Principle | Target Modification(s) | Single-Base Resolution |
Key Advantages |
|---|---|---|---|---|
| ACE-Seq | Enzymatic deamination (APOBEC3A selectively deaminates C/5mC, but not 5hmC) | 5hmC | Yes | Minimal DNA damage; low input requirement; bisulfite-free |
| TAB-Seq | βGT glucosylation of 5hmC → TET oxidation of 5mC → bisulfite conversion | 5hmC | Yes | High specificity; considered a gold standard for 5hmC mapping |
| oxBS-Seq | KRuO₄ oxidation of 5hmC to 5fC → bisulfite conversion | 5mC (5hmC inferred by subtraction from BS-Seq) | Yes | Enables quantitative separation of 5mC and 5hmC |
| EM-Seq | TET2 oxidation of 5mC → 5caC; APOBEC deamination of unmodified C (± βGT for 5hmC) | 5mC (standard); 5mC + 5hmC (with βGT pre-treatment) | Yes | low DNA damage; ultra-low input compatible; compatible with long-read sequencing |
While traditional 5hmC profiling methods like oxBS-Seq are hampered by high cost, substantial DNA input requirements, and damaging chemical treatment, ACE Sequencing provides an elegant solution. Our technology delivers:
ACE Sequencing empowers discovery across diverse biological fields:
ACE Sequencing detects disease-specific 5hmC "signatures" that appear early in tissues and liquid biopsies (e.g., cfDNA). These highly sensitive epigenetic biomarkers support biomarker discovery, cohort stratification, and mechanism studies using tissue or cfDNA in research settings.
ACE Sequencing maps 5hmC dynamics at single-base resolution during critical processes like embryogenesis and stem cell differentiation. By pinpointing 5hmC at gene regulators, it reveals how this modification acts as a precise epigenetic switch controlling cell-specific gene expression, providing foundational insights for developmental biology and regenerative medicine.
This application studies how organisms rapidly reprogram their 5hmC landscape in response to stresses like drought or disease. ACE Sequencing identifies the specific genes and pathways regulated by these epigenetic changes, offering direct targets for breeding more resilient crops and improving animal health management.
ACE Sequencing discovers stable 5hmC patterns linked to superior agricultural traits (e.g., yield, growth rate). These epigenetic markers enable novel, non-genetic breeding strategies, accelerating the development of improved plant varieties and animal breeds through precise trait optimization.
CD Genomics offers comprehensive and flexible bioinformatics analysis services, ranging from basic data processing to advanced customized analyses. Our solutions facilitate in-depth exploration of genomic variations and functionalities.
Standard Analysis
Advanced & Custom Analysis:
The following figures display a portion of the data.
| Sample Type | Minimum Amount | Quality Notes |
|---|---|---|
| Genomic DNA | ≥ 100 ng | High purity (A260/280 ≈ 1.8), in TE or water. |
| Fresh/Frozen Tissue | ≥ 10 mg | Snap-frozen, avoid RNAlater. |
| Cultured Cells | ≥ 2 x 106 cells | Pelleted, washed with PBS. |
| Whole Blood | 0.5–2 mL | EDTA or citrate tubes preferred. |
| FFPE Sections | ≥ 15 slides (4-10 µm) | Tumor cell purity >30% recommended. |
| Plasma/Serum cfDNA | ≥ 15 ng cfDNA | Isolated using recommended kits. |
| Other Types | Please Inquire | Saliva, urine, microbiome DNA, etc. |
Shipment: Ship samples on dry ice. Contact us for detailed preparation guidelines.
Choosing a service provider is about partnership, expertise, and guaranteed quality. At CD Genomics, we combine cutting-edge technology with unwavering scientific rigor to ensure your project's success.
Our scientists are not just sequencing technicians; they are experts in epigenetic assay development and optimization. We understand the nuances of 5hmC biology and data interpretation, providing you with insightful consultation from project design to discussion.
You will be assigned a dedicated project manager and a team of expert analysts. This single point of contact ensures clear communication, timely updates, and seamless coordination across our wet-lab and bioinformatics teams, giving you peace of mind.
Quality is embedded at every step. We perform stringent QC on incoming samples, monitor conversion efficiency post-enzymatic treatment, assess library quality, and validate data output. Our transparent QC reports give you confidence in the foundational data driving your discoveries.
We run projects on calibrated Illumina NovaSeq & NextSeq systems. Our ACE-seq workflow is optimized and routinely monitored with spike-in controls and reference samples for consistent performance across projects.
We deliver more than just FASTQ files. Our analysis pipeline is curated to yield biologically meaningful results, presented in clear, publication-ready figures and comprehensive reports. We focus on turning data into your next discovery.
We view each project as a collaboration. Whether you need a standard whole-genome profile or a custom-targeted panel, our team works flexibly to tailor the service to your specific hypotheses, budget, and sample types.
References
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.
Quote Request